Bio prospects for CEO
Tuesday, 23 September, 2008
Peter May has been appointed as the new CEO of Brisbane agribiotech BioProspect, taking over from Warwick Dowse, who has returned to New Zealand.
May has previously worked with CFL, Incitec and Crop Care Australasia, and has run his own consultancy since 2001, working with the likes of Syngenta. He will officially take up the job on November 3.
BioProspect focuses on the discovery, research and development of commercial products from Australian botanical sources.
It is currently developing two main products: a natural termite compound called Termilone and a range of natural plant extracts for application in the animal nutrition, health and agricultural markets called Bioeffectives.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
